Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase

被引:47
作者
Arimondo, PB
Boutorine, A
Baldeyrou, B
Bailly, C
Kuwahara, M
Hecht, SM
Sun, JS
Garestier, T
Hélène, C
机构
[1] Museo Nacl Hist Nat, Biophys Lab, UMR 8646 CNRS, INSERM U201, F-75231 Paris 05, France
[2] Inst Rech Canc Lille, Ctr Oscar Lambret, INSERM U524, F-59045 Lille, France
[3] Inst Rech Canc Lille, Ctr Oscar Lambret, Lab Pharmacol Antitumorale, F-59045 Lille, France
[4] Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA
关键词
D O I
10.1074/jbc.M110181200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To achieve a sequence-specific DNA cleavage by topoisomerase 1, derivatives of the antitumor drug camptothecin have been covalently linked to triple helix-forming oligonucleotides that bind in a sequence-specific manner to the major groove of double-helical DNA. Triplex formation at the target sequence positions the drug selectively at the triplex site, thereby stimulating topoisomerase I-mediated DNA cleavage at this site. In a continuous effort to optimize this strategy, a broad set of conjugates consisting of (i) 16-20-base-long oligonucleotides, (ii) alkyl linkers of variable length, and (iii) camptothecin derivatives substituted on the A or B quinoline ring were designed and synthesized. Analysis of the cleavage sites at nucleotide resolution reveals that the specificity and efficacy of cleavage depends markedly on the length of both the triple-helical structure and the linker between the oligonucleotide and the poison. The optimized hybrid molecules induced strong and highly specific cleavage at a site adjacent to the triplex. Furthermore, the drug-stabilized DNA-topoisomerase I cleavage complexes were shown to be more resistant to salt-induced reversal than the complexes induced by camptothecin alone. Such rationally designed camptothecin conjugates could provide useful antitumor drugs directed selectively against genes bearing the targeted triplex binding site. In addition, they represent a powerful tool to probe the molecular interactions in the DNA-topoisomerase I complex.
引用
收藏
页码:3132 / 3140
页数:9
相关论文
共 23 条
  • [11] Cell death induced by topoisomerase-targeted drugs: more questions than answers
    Kaufmann, SH
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3): : 195 - 211
  • [12] Modulation of camptothecin analogs in the treatment of cancer: a review
    Kehrer, DFS
    Soepenberg, O
    Loos, WJ
    Verweij, J
    Sparreboom, A
    [J]. ANTI-CANCER DRUGS, 2001, 12 (02) : 89 - 105
  • [13] A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin
    Kerrigan, JE
    Pilch, DS
    [J]. BIOCHEMISTRY, 2001, 40 (33) : 9792 - 9798
  • [14] Stabilization of triple helical DNA by a benzopynidoquinoxaline intercalator
    Marchand, C
    Bailly, C
    Nguyen, CH
    Bisagni, E
    Garestier, T
    Helene, C
    Waring, MJ
    [J]. BIOCHEMISTRY, 1996, 35 (15) : 5022 - 5032
  • [15] Sequence-specific targeting of duplex DNA using a camptothecin triple helix forming oligonucleotide conjugate and topoisomerase I
    Matteucci, M
    Lin, KY
    Huang, T
    Wagner, R
    Sternbach, DD
    Mehrotra, M
    Besterman, JM
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (29) : 6939 - 6940
  • [16] Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
    Pommier, Y
    Pourquier, P
    Fan, Y
    Strumberg, D
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3): : 83 - 106
  • [17] Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA
    Redinbo, MR
    Stewart, L
    Kuhn, P
    Champoux, JJ
    Hol, WGJ
    [J]. SCIENCE, 1998, 279 (5356) : 1504 - 1513
  • [18] Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA
    Redinbo, MR
    Champoux, JJ
    Hol, WGJ
    [J]. BIOCHEMISTRY, 2000, 39 (23) : 6832 - 6840
  • [19] SAWADA S, 1991, CHEM PHARM BULL, V39, P2574
  • [20] A model for the mechanism of human topoisomerase I
    Stewart, L
    Redinbo, MR
    Qiu, XY
    Hol, WGJ
    Champoux, JJ
    [J]. SCIENCE, 1998, 279 (5356) : 1534 - 1541